Recent SRZN News
- Surrozen to Present at Upcoming Healthcare Investor Conferences • GlobeNewswire Inc. • 11/06/2024 09:30:40 PM
- Surrozen Provides Third Quarter 2024 Financial Results and Business Update • GlobeNewswire Inc. • 11/06/2024 02:00:09 PM
- Surrozen and TCGFB, Inc. Announce Strategic Research Collaboration to Develop TGF-β Antibodies for Idiopathic Pulmonary Fibrosis • GlobeNewswire Inc. • 11/04/2024 01:30:55 PM
- Surrozen Earns $10 Million Milestone Payment in Retinal Diseases Collaboration • GlobeNewswire Inc. • 09/24/2024 12:30:23 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/12/2024 08:14:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/12/2024 08:08:28 PM
- Surrozen Provides Second Quarter 2024 Financial Results and Business Update • GlobeNewswire Inc. • 08/12/2024 08:05:09 PM
- Surrozen Publishes Study in ‘eLife’ Demonstrating the Promise of The Proprietary SWEETS Platform, a Unique Targeted Protein Degradation Technology, to Further Enhance Wnt Signaling • GlobeNewswire Inc. • 06/12/2024 12:30:36 PM
- Surrozen Presents Preliminary Results from Phase 1a Study of SZN-043 in Healthy Volunteers and Patients with a History of Liver Cirrhosis at the 2024 European Association for the Study of the Liver (EASL) in Milan • GlobeNewswire Inc. • 06/10/2024 12:30:01 PM
- Surrozen Initiates Dosing of First Patient in Phase 1b Clinical Trial of SZN-043 for Severe Alcohol-Associated Hepatitis • GlobeNewswire Inc. • 06/04/2024 12:30:16 PM
- Surrozen Presents Data Demonstrating the Promise of Antibody-Based Wnt Mimetics in Treating Cornea Endothelial Dystrophies and Dry Eye Disease at the Associations for Research in Vision and Ophthalmology (ARVO) Annual Meeting • GlobeNewswire Inc. • 05/09/2024 12:30:24 PM
- Surrozen Provides First Quarter 2024 Financial Results and Business Update • GlobeNewswire Inc. • 05/08/2024 08:05:00 PM
- Surrozen Publishes Study in 'Respiratory Research' Demonstrating the Promise of a Wnt Mimetic Antibody in Treating Pulmonary Fibrosis • GlobeNewswire Inc. • 04/03/2024 12:40:07 PM
- Surrozen Announces Safety, Pharmacodynamic and Liver Function Data for SZN-043 • GlobeNewswire Inc. • 04/01/2024 12:30:54 PM
- Surrozen Announces up to $192.5 Million Private Placement of Securities Priced At-the-Market Under Nasdaq Rules • GlobeNewswire Inc. • 04/01/2024 12:30:11 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 02/07/2024 11:16:31 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/07/2024 11:10:12 AM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 01/22/2024 10:24:24 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/18/2024 01:41:46 PM
- Surrozen Provides Corporate Update on Clinical Programs • GlobeNewswire Inc. • 01/18/2024 01:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/19/2023 02:26:15 AM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 12/13/2023 10:21:50 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/13/2023 10:14:53 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 12/11/2023 09:11:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/11/2023 09:08:09 PM
SANUWAVE Announces Record Quarterly Revenues: Q3 FY2024 Financial Results • SNWV • Nov 8, 2024 7:07 AM
DBG Pays Off $1.3 Million in Convertible Notes, which Retires All of the Company's Convertible Notes • DBGI • Nov 7, 2024 2:16 PM
SMX and FinGo Enter Into Collaboration Mandate to Develop a Joint 'Physical to Digital' Platform Service • SMX • Nov 7, 2024 8:48 AM
Rainmaker Worldwide Inc. (OTC: RAKR) Announces Successful Implementation of 1.6 Million Liter Per Day Wastewater Treatment Project in Iraq • RAKR • Nov 7, 2024 8:30 AM
SBC Medical Group Holdings and MEDIROM Healthcare Technologies Announce Business Alliance • SBC • Nov 7, 2024 7:00 AM
VAYK Confirms Insider Buying at Open Market • VAYK • Nov 5, 2024 10:40 AM